PR1 Peptide Vaccine May Aid Leukemia Remission PR1 Peptide Vaccine May Aid Leukemia Remission

PR1 peptide vaccine may benefit many patients with myeloid leukemia, chronic myeloid leukemia and myelodysplastic syndrome, findings from an early clinical trial suggest.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news

Related Links:

ConclusionAdding neoadjuvant chemotherapy to S or RT cannot be recommended outside the context of clinical trials.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
GIDEON what’s new summary: October 13 to October 15, 2018 Infectious Diseases – Outbreaks (15 updates) 15 DiseasesMap Infectious Diseases – Diseases (418 updates) 152 Clinical notes79 Diseases187 Country notesMap Infectious Diseases – Drugs (14 updates) 1 New Drugs Added1 Drug1 New Drug Synonyms Added11 Drug interactions – New Infectious Diseases – Vaccines (1 updates) 1 Vaccine The post Update: October 15, 2018 appeared first on GIDEON - Global Infectious Diseases and Epidemiology Online Network.
Source: GIDEON blog - Category: Databases & Libraries Authors: Tags: What's New Source Type: blogs
ConclusionsThe treatment landscape for mccRCC has evolved since the introduction of VEGF inhibitors. Combination therapies involving checkpoint inhibitors could be the next standard of care.Patient summaryWith the expanding role of immune checkpoint inhibitors in metastatic renal cell carcinoma, the treatment paradigm has shifted to include combination therapy in the untreated setting. As the field advances, the bar has been raised in evaluating ongoing combination strategies.
Source: European Urology - Category: Urology & Nephrology Source Type: research
Pediatric Blood&Cancer, EarlyView.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Source Type: research
Pediatric Blood&Cancer, EarlyView.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Source Type: research
. Belov The high human cost of Zika virus infections and the rapid establishment of virus circulation in novel areas, including the United States, present an urgent need for countermeasures against this emerging threat. The development of an effective vaccine against Zika virus may be problematic because of the cross reactivity of the antibodies with other flaviviruses leading to antibody-dependent enhancement of infection. Moreover, rapidly replicating positive strand RNA viruses, including Zika virus, generate large spectrum of mutant genomes (quasi species) every replication round, allowing rapid selection of varian...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
Cancer Medicine, EarlyView.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Source Type: research
SMC3 protein levels impact on karyotype and outcome in acute myeloid leukemia, Published online: 15 October 2018; doi:10.1038/s41375-018-0287-6SMC3 protein levels impact on karyotype and outcome in acute myeloid leukemia
Source: Leukemia - Category: Hematology Authors: Source Type: research
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse, Published online: 15 October 2018; doi:10.1038/s41375-018-0271-1Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse
Source: Leukemia - Category: Hematology Authors: Source Type: research
Publication date: Available online 13 October 2018Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Benjamin L. Wright, Matthew A. Rank
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Chronic Leukemia | Chronic Myeloid Leukaemia | Clinical Trials | International Medicine & Public Health | Leukemia | Myelodysplastic Syndrome | Vaccines